205 related articles for article (PubMed ID: 1803887)
41. MRI of pituitary adenomas in acromegaly.
Marro B; Zouaoui A; Sahel M; Crozat N; Gerber S; Sourour N; Sag K; Marsault C
Neuroradiology; 1997 Jun; 39(6):394-9. PubMed ID: 9225316
[TBL] [Abstract][Full Text] [Related]
42. Varied microcirculation of pituitary adenomas at rapid, dynamic, contrast-enhanced MR imaging.
Finelli DA; Kaufman B
Radiology; 1993 Oct; 189(1):205-10. PubMed ID: 8372195
[TBL] [Abstract][Full Text] [Related]
43. Cavernous sinus invasion by pituitary adenomas.
Ahmadi J; North CM; Segall HD; Zee CS; Weiss MH
AJR Am J Roentgenol; 1986 Feb; 146(2):257-62. PubMed ID: 3484572
[TBL] [Abstract][Full Text] [Related]
44. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
[TBL] [Abstract][Full Text] [Related]
45. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
46. Treatment of intracavernous extensions of pituitary adenomas.
MacKay A; Hosobuchi Y
Surg Neurol; 1978 Dec; 10(6):377-83. PubMed ID: 741360
[TBL] [Abstract][Full Text] [Related]
47. [Prognostic value of the Knosp scale in trans-sphenoidal surgery for pituitary adenomas].
Zieliński G; Podgórski JK
Neurol Neurochir Pol; 2002; 36(1):69-82. PubMed ID: 12053617
[TBL] [Abstract][Full Text] [Related]
48. Cavernous sinus compartments from the endoscopic endonasal approach: anatomical considerations and surgical relevance to adenoma surgery.
Fernandez-Miranda JC; Zwagerman NT; Abhinav K; Lieber S; Wang EW; Snyderman CH; Gardner PA
J Neurosurg; 2018 Aug; 129(2):430-441. PubMed ID: 28862552
[TBL] [Abstract][Full Text] [Related]
49. Relationships among DNA Index, S-Phase, and invasive behavior in anterior pituitary adenomas. A cytometric study of 61 cases with Feulgen-positive DNA analysis.
Mastronardi L; Guiducci A; Buttaro FM; Cristallini EG; Puzzilli F; Maira G
Surg Neurol; 2001 Jul; 56(1):27-32. PubMed ID: 11546567
[TBL] [Abstract][Full Text] [Related]
50. MRI of pituitary adenomas: the position of the normal pituitary gland.
Sumida M; Uozumi T; Mukada K; Arita K; Kurisu K; Yano T; Onda J; Satoh H; Ikawa F
Neuroradiology; 1994 May; 36(4):295-7. PubMed ID: 8065574
[TBL] [Abstract][Full Text] [Related]
51. Pituitary microadenomas. Does Gadolinium enhance their demonstration?
Macpherson P; Hadley DM; Teasdale E; Teasdale G
Neuroradiology; 1989; 31(4):293-8. PubMed ID: 2677826
[TBL] [Abstract][Full Text] [Related]
52. Effective performance of contrast enhanced SPACE imaging in clearly depicting the margin of pituitary adenoma.
Wu Y; Wang J; Yao Z; Yang Z; Ma Z; Wang Y
Pituitary; 2015 Aug; 18(4):480-6. PubMed ID: 25236436
[TBL] [Abstract][Full Text] [Related]
53. Pituitary Adenoma: A review of existing classification systems based on anatomic extension and invasion.
Hashmi FA; Shamim MS
J Pak Med Assoc; 2020 Feb; 70(2):368-370. PubMed ID: 32063639
[TBL] [Abstract][Full Text] [Related]
54. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population.
Hall WA; Luciano MG; Doppman JL; Patronas NJ; Oldfield EH
Ann Intern Med; 1994 May; 120(10):817-20. PubMed ID: 8154641
[TBL] [Abstract][Full Text] [Related]
55. Dynamic CT scanning for the evaluation of pituitary tumor invasion to the cavernous sinus.
Inoue Y; Hakuba A; Takemoto K; Nemoto Y; Oda J; Onoyama Y; Nishio A; Nishimura S
Radiat Med; 1985; 3(4):192-6. PubMed ID: 3836437
[TBL] [Abstract][Full Text] [Related]
56. Endoscopic Endonasal Surgery for Tumors of the Cavernous Sinus: A Series of 234 Patients.
Koutourousiou M; Vaz Guimaraes Filho F; Fernandez-Miranda JC; Wang EW; Stefko ST; Snyderman CH; Gardner PA
World Neurosurg; 2017 Jul; 103():713-732. PubMed ID: 28450229
[TBL] [Abstract][Full Text] [Related]
57. A clinical and histopathological study of factors affecting MRI signal intensities of pituitary adenomas.
Kobayashi S; Ikeda H; Yoshimoto T
Neuroradiology; 1994 May; 36(4):298-302. PubMed ID: 8065575
[TBL] [Abstract][Full Text] [Related]
58. Thin-Slice Pituitary MRI with Deep Learning-Based Reconstruction for Preoperative Prediction of Cavernous Sinus Invasion by Pituitary Adenoma: A Prospective Study.
Kim M; Kim HS; Park JE; Park SY; Kim YH; Kim SJ; Lee J; Lebel MR
AJNR Am J Neuroradiol; 2022 Feb; 43(2):280-285. PubMed ID: 34992127
[TBL] [Abstract][Full Text] [Related]
59. A new endoscopic surgical classification and invasion criteria for pituitary adenomas involving the cavernous sinus.
Ceylan S; Anik I; Koc K
Turk Neurosurg; 2011; 21(3):330-9. PubMed ID: 21845568
[TBL] [Abstract][Full Text] [Related]
60. MRI of growth hormone-secreting pituitary adenomas: factors determining pretreatment hormone levels.
Saeki N; Iuchi T; Isono S; Eda M; Yamaura A
Neuroradiology; 1999 Oct; 41(10):765-71. PubMed ID: 10552028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
